Biogen-Idec and Columbia University Collaborate on Genetic Research and ALS

Biogen-Idec has entered into a $30M alliance with Columbia University Medical Center in New York, NY, to collaborate on genetic research that will include studies in ALS. Under the collaboration, a new postdoctoral program and sequencing facility will be established and new large-scale genomic studies into diseases with significant unmet need will be initiated. David Goldstein, who joined Columbia University in January as director of the new Institute for Genomic Medicine, plans to expand the number of ALS-focused genetic studies at the Institute as part of this collaboration.

Click here to read more.

disease-als topic-genetics
Share this: